T45.695
Adverse effect of other fibrinolysis-affecting drugs
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code T45.695 refers to adverse effects caused by drugs that influence fibrinolysis, a process in the body responsible for breaking down blood clots. These medications are crucial in treating conditions like blood clots and strokes, but in some cases, they can cause unintended side effects. Recognizing these adverse effects is important for healthcare providers and patients alike to ensure safe and effective treatment.
Causes & Symptoms
Clinical Causes: Use of fibrinolytic or fibrinolysis-affecting medications Incorrect dosage or administration of such drugs Patient’s sensitivity or allergic reaction to the medication Interaction of fibrinolytic drugs with other medications or substances Underlying health conditions that increase susceptibility to bleeding or other adverse effects
Key Symptoms: Unusual bleeding or excessive bruising Blood in urine or stool Nosebleeds or bleeding gums Pain and swelling at injection or infusion sites Signs of internal bleeding such as dizziness or lightheadedness Allergic reactions like rash, itching, or swelling
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves reviewing the patient's medication history and recent treatment approaches. Healthcare providers may perform blood tests such as coagulation profiles, platelet counts, and imaging studies if internal bleeding is suspected. Monitoring the patient closely after administering fibrinolytic drugs helps detect adverse effects early.
Treatment Protocols: Managing adverse effects involves immediate cessation of the causative medication and supportive care tailored to the severity of the symptoms. Treatments may include blood transfusions, medication to reverse the effects of bleeding, or supportive measures like IV fluids. Prevention involves careful dosing, monitoring, and patient education to identify early signs of adverse reactions.
Clinical Advice & FAQs
Billing Guidance
Is T45.695 a billable ICD-10 code?
Yes, T45.695 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.695?
Clinical documentation must specify the nature of Adverse effect of other fibrinolysis-affecting drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference